LPA1 ANTAGONISTS FOR TREATING INTERSTITIAL LUNG DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240252476A1
SERIAL NO

18393940

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure relates to methods of treating interstitial lung disease by administering an LPA1 antagonist to the subject at one or more daily dosages lower than the standard daily dosage during a dose titration period of treatment then increasing the dosage to the standard daily dosage of the LPA1 antagonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRISTOL-MYERS SQUIBB COMPANYROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FISCHER, Aryeh Denver, US 3 0
GREENBERG, Steven Pittstown, US 30 1762
PARKAR, Ashfaq A Kendall Park, US 2 0
TAO, Shiwei Hillsborough, US 30 189
TATOSIAN, Daniel A Berkeley Heights, US 5 1
TIRUCHERAI, Giridhar S Kendall Park, US 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation